Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications    » Alzheimer's    » Amputations    » Blindness    » Bone Loss    » Broken Bones    » Cancer    » Cardiovascular    » Cholesterol    » Cognitive Function    » Complications    » Death    » Dementia    » Dental    » Depression    » Eyes    » Feet    » Foot Ulcers    » Hearing Loss    » Heart Disease    » Hypertension    » Hypoglycemia    » Kidney Disease    » Lung    » Memory    » Neuropathy    » PAD    » Pain    » PCOS    » Pneumonia    » Retinopathy    » Stress    » Stroke    » Wounds Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Complications

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Definition of Metabolic Syndrome Posted: Wednesday, October 21, 2009

A new joint statement from a number of professional organizations has identified specific criteria for the clinical diagnosis of metabolic syndrome, tightening up the definition, which previously differed from one organization to the next.

Positive Results for a New First in Class Diabetes Drug Posted: Wednesday, October 21, 2009

MBX-2982 could be a potential first-in-class treatment for Type 2 diabetes that may offer improved glucose homeostasis over existing therapies.

Emergency Doctors Rarely Adjust Antibiotic Doses for Obese Patients Posted: Wednesday, October 21, 2009

Emergency department physicians rarely adjust antimicrobial medication doses for obese patients, according to new research.

Obese Diabetics Who Fail Oral Therapy Can Benefit from Gastric Electrical Stimulation Posted: Wednesday, October 21, 2009

Gastric electrical stimulation is a reasonable alternative to insulin and oral hypoglycemic agents in obese Type 2 diabetics who are poorly controlled by oral agents and who are not candidates for gastric bypass surgery.

Targeting the Brain with Resveratrol to Treat Diabetes Posted: Wednesday, October 14, 2009

Resveratrol, a molecule found in red grapes, has been shown to improve diabetes when delivered orally. Until now, however, little has been known about how these beneficial changes are mediated in the body.

EASD: Lidocaine Patch Beats Pregabalin for Diabetic Nerve Pain Posted: Wednesday, October 07, 2009

A dermal patch containing 5% lidocaine (Lidoderm) proved as effective as pregabalin (Lyrica) in relieving neuropathic pain in diabetic patients with dramatically fewer side effects.

EASD: AFRESA® Phase 3 Data Show Sustained Glycemic Control, Normal Lung Function in Patients over Four Years of Treatment Posted: Wednesday, October 07, 2009

Long-term study in adults with Type 2 diabetes presented at the 45th annual meeting of the European Association for the Study of Diabetes.

Three Inexpensive Drugs Reduce Heart Attack, Stroke Risks by 80% Posted: Wednesday, October 07, 2009

People who are at high risk of experiencing a heart attack or stroke can reduce their risk by up to 80 percent if they take a combination of three inexpensive drugs, according to a new study.

Healthy Lifestye Factors Can Reduce Deadly Chronic Diseases by 80% Posted: Wednesday, October 07, 2009

Four healthy lifestyle factors -- never smoking, maintaining a healthy weight, exercising regularly and following a healthy diet -- together appear to be associated with as much as an 80 percent reduction in the risk of developing the most common and deadly chronic diseases, according to a report in Archives of Internal Medicine.

EASD: New First in Class Drug Effective in Phase III Trial Posted: Wednesday, October 07, 2009

An investigational drug targeting an insulin-independent pathway in Type 2 diabetes produced early and substantial reductions in blood glucose and body weight in a phase III study.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.